PMN: Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays

Product code PMN, “Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays” in FDA's classification database, is a Class II device type under 21 CFR 866.3920 (assayed quality control material for clinical microbiology assays), reviewed by FDA's Microbiology panel. FDA's 510(k) database lists 32 clearances under PMN, 32 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
PMN
Regulation
21 CFR 866.3920
Class
II
Panel
Microbiology
Clearances
32
Most recent
Jul 17, 2026
Median review, last 2 years
86 days
Third-party review
Eligible
Implant
No

What it covers

Assayed external quality control material to monitor the performance of microbiology nucleic acid assays for in vitro diagnostic use.

FDA’s definition of product code PMN, from the Product Classification database.

Recent clearances

510(k)DeviceApplicantDecisionType
K261475BIOFIRE® FILMARRAY® Tropical Fever Panel Control KitBiofire Defense, LLCJul 17, 2026Traditional
K260577FilmArray TF Control Panel M527Maine Molecular Quality Controls, Inc.May 19, 2026Traditional
K260041MDx-Chex for BCPStreck, LLCMar 27, 2026Traditional
K254166MDx-Chex for BCNStreckMar 23, 2026Traditional
K254167MDx-Chex for BCYStreck, LLCMar 17, 2026Traditional
K251526FilmArray GI Control Panel M238Maine Molecular Quality Controls, Inc.Aug 14, 2025Traditional
K241289SPOTFIRE RSP Pos & Neg Controls; SPOTFIRE RSP Negative ControlMaine Molecular Quality Controls, Inc.May 30, 2024Special
K233611SPOTFIRE RSP Pos & Neg Controls (M425), SPOTFIRE RSP Positive Control (M42638), SPOTFIRE RSP Negative Control (M42738)Maine Molecular Quality Controls, Inc.Mar 26, 2024Traditional
K231221MDx-Chex for BC-GPStreckJul 27, 2023Traditional
K231223MDx-Chex for BC-GNStreckJul 27, 2023Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 32 with a free account)

Clearances by year

32 PMN 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)584
2025187
2024279
2023490
20223582
20211323
2020292
2019671
2018359
2017273
20163103

Who submits

8 applicants cleared a PMN device since 2011. 100% of the clearances went to applicants in United States. By type: Traditional 91%, Special 6% and Post-NSE 3%.

ApplicantClearances since 2011
Maine Molecular Quality Controls, Inc.13
Microbiologics, Inc.8
Streck3
Bio-Rad Laboratories2
Biofire Defense, LLC2
Streck, LLC2
Streck, Inc.1
Zeptometrix1

How FDA classifies it

Class II (special controls). The special controls for this device are:

(1) Premarket notification submissions must include detailed device description documentation and information concerning the composition of the quality control material, including, as appropriate:

(i) Analyte concentration;

(ii) Expected values;

(iii) Analyte source;

(iv) Base matrix;

(v) Added components;

(vi) Safety and handling information; and

(vii) Detailed instructions for use.

(2) Premarket notification submissions must include detailed documentation, including line data as well as detailed study protocols and a statistical analysis plan used to establish performance, including:

(i) Description of the process for value assignment and validation.

(ii) Description of the protocol(s) used to establish stability.

(iii) Line data establishing precision/reproducibility.

(iv) Where applicable, assessment of matrix effects and any significant differences between the quality control material and typical patient samples in terms of conditions known to cause analytical error or affect assay performance.

(v) Where applicable, identify or define traceability or relationship to a domestic or international standard reference material and/or method.

(vi) Where applicable, detailed documentation related to studies for surrogate controls.

(3) Premarket notification submissions must include an adequate mitigation (e.g., real-time stability program) to the risk of false results due to potential modifications to the assays specified in the device's 21 CFR 809.10 compliant labeling.

(4) Your 21 CFR 809.10 compliant labeling must include the following:

(i) The intended use of your 21 CFR 809.10(a)(2) and (b)(2) compliant labeling must include the following:

(A) Assayed control material analyte(s);

(B) Whether the material is intended for quantitative or qualitative assays;

(C) Stating if the material is a surrogate control; and

(D) The system(s), instrument(s), or test(s) for which the quality control material is intended.

(ii) The intended use in your 21 CFR 809.10(a)(2) and (b)(2) compliant labeling must include the following statement: “This product is not intended to replace manufacturer controls provided with the device.”

(iii) A limiting statement that reads “Quality control materials should be used in accordance with local, state, federal regulations, and accreditation requirements.”

From 21 CFR 866.3920. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 866.3920 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent PMN clearances declared.

Ask about PMN

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about PMN

What is FDA product code PMN?

Product code PMN, “Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays” in FDA's classification database, is a Class II device type under 21 CFR 866.3920 (assayed quality control material for clinical microbiology assays), reviewed by FDA's Microbiology panel. FDA's 510(k) database lists 32 clearances under PMN, 32 of them since 2011.

How many 510(k) clearances are there under PMN?

FDA’s 510(k) database listed 32 clearances under PMN as of Oct 29, 2026, 32 of them decided since 2011; the most recent decision was Jul 17, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a PMN 510(k)?

For the 6 PMN clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 86 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most PMN clearances?

Since 2011: Maine Molecular Quality Controls, Inc. (13), Microbiologics, Inc. (8), Streck (3), Bio-Rad Laboratories (2) and Biofire Defense, LLC (2). 8 applicants have cleared a PMN device in that time.

Sources

  1. FDA product classification: PMN · Product Classification database
  2. 21 CFR 866.3920: Assayed quality control material for clinical microbiology assays · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for PMN · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow PMNGet an email when FDA clears, recalls or publishes guidance for PMN devices.

Know what FDA already cleared.